Open Nav

QT Medical

  • Ruey-Kang Chang, QT Medical

Seeking Series A investors, partners

  • Date:Wednesday, October 17
  • Time:3:15 PM - 3:30 PM
  • Room:Olympic
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:QT Medical is a medtech startup focusing on electrocardiogram (ECG). We make the first and only hospital-quality 12-lead ECG for patients to use at home. The first product QT ECG received FDA clearance in May 2018. Our mission is to bring the most useful cardiac test-- 12-lead ECG, to the homes of millions of patients with heart disease. We will focus initially on CRO/clinical trial market and telemedcine, then move on to post-op and home cardiac care later.
  • Company
  • Company HQ City:Torrance, CA
  • Company HQ Country:United States
  • Company HQ State:California                  
  • CEO/Top Company Official:Ruey-Kang Chang
  • Year Founded:2013
  • Main Therapeutic Focus:Cardiovascular
  • Lead Product in Development :QT ECG
  • Development Phase of Primary Product:Phase IV
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :0
  • Additional Information/Comments:We are now raising Series A of $10,000,000 to prepare for product launch. I would like to meet with investors interested in cardiovascular market, home care, telemedicine, senior care, big data/AI, and medical technologies to discuss our Series A offer. I would also like to meet pharmaceutical companies and CROs for a discussion of using QT ECG to facilitate the cardiac safety testing in clinical trials.
  • Previous and Current Investors:Founders, Board members, families and friends
  • Size of Last Investment Round:$1,300,000
  • Total Amount Raised to Date, In All Rounds:$5,500,000
Ruey-Kang Chang
QT Medical